Sukyung Woo, Ph.D.
Affiliations: | 2007 | Pharmaceutical Sciences | State University of New York, Buffalo, Buffalo, NY, United States |
Google:
"Sukyung Woo"Parents
Sign in to add mentor| William J. Jusko | grad student | 2007 | SUNY Buffalo | |
| (Disposition and dynamics of recombinant human erythropoietin.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sharma A, Li M, Thavathiru E, et al. (2020) Physiologically Based Pharmacokinetic Modeling and Tissue Distribution Characteristics of SHetA2 in Tumor-Bearing Mice. The Aaps Journal. 22: 51 |
| Lim SY, Sharan S, Woo S. (2020) Model-Based Analysis of Cannabidiol Dose-Exposure Relationship and Bioavailability. Pharmacotherapy |
| Subramaniyan B, Rajaputra P, Nguyen L, et al. (2019) Local and Systemic Antitumor Effects of Photo-activatable Paclitaxel Prodrug on Rat Breast Tumor Models. Photochemistry and Photobiology |
| Nguyen L, Li M, Woo S, et al. (2019) Development of Prodrugs for PDT-Based Combination Therapy Using a Singlet-Oxygen-Sensitive Linker and Quantitative Systems Pharmacology. Journal of Clinical Medicine. 8 |
| Li M, Nguyen L, Subramaniyan B, et al. (2019) PBPK modeling-based optimization of site-specific chemo-photodynamic therapy with far-red light-activatable paclitaxel prodrug. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Sharma A, Benbrook DM, Woo S. (2018) Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2. Plos One. 13: e0194046 |
| Ibach BW, Miller JL, Woo S, et al. (2017) Characterization of Tolerance in Children during Fentanyl Continuous Infusions. Journal of Pediatric Intensive Care. 6: 83-90 |
| Li M, Thapa P, Rajaputra P, et al. (2017) Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system. Journal of Pharmacokinetics and Pharmacodynamics |
| Thapa P, Li M, Bio M, et al. (2016) Abstract 1361: Progress in light activatable prodrug for the combinational treatment of PDT and site-specific chemotherapy: paclitaxel prodrugs Cancer Research. 76: 1361-1361 |
| Devapatla B, Sharma A, Woo S. (2015) CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer. Plos One. 10: e0139237 |